Patents by Inventor Thomas Witzig

Thomas Witzig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050113403
    Abstract: This invention provides the use of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of mantle cell lymphoma.
    Type: Application
    Filed: November 2, 2004
    Publication date: May 26, 2005
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Thomas Witzig, Scott Kaufmann